Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of iLivTouch and FibroScan for the Assessment of Liver Fibrosis and Steatosis in Adult Patients in the US: A Multicenter, Cross-sectional, and Prospective Study

NCT06051669 is registered in ClinicalTrials.gov with New Discovery LLC as lead sponsor.

NCT NCT06051669
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06051669 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of iLivTouch and FibroScan for the Assessment of Liver Fibrosis and Steatosis in Adult Patients in the US: A Multicenter, Cross-sectional, and Prospective Study
Lead sponsor
New Discovery LLC
Phase
Observational
Overall status
Unknown status
Start date
September 24, 2023
Completion date
March 31, 2025
Enrollment
418 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

fatty liver, liver fibrosis